Lung cancer is the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for approximately 83% of all lung cancers and occurring primarily in older patients with a median age at diagnosis of 70 years. These statistics emphasize an educational need for health care professionals to know how to assess older patients with NSCLC, to determine risk for adverse outcomes from cancer treatment, and to identify treatment options that may be more appropriate for older patients at higher risk.

With the emergence of new therapeutic interventions and systemic therapies for NSCLC and advances in lung cancer screening, clinicians continue to rely on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Non-Small Cell Lung Cancer, the NCCN Guidelines® for Older Adult Oncology, and NCCN’s educational interventions to increase their knowledge and to bridge the gap between knowledge and clinical practice. With these resources, NCCN seeks to assist clinicians in communicating management options effectively to their patients, making shared treatment decisions, and providing optimal care.

This congress is designed to educate healthcare professionals on current and emerging scientific data so that they can make evidence-based decisions about screening and treatment for patients with NSCLC. The goal of this educational program is to ensure that members of a multidisciplinary team, including physicians, nurses, pharmacists, and other relevant healthcare professionals, have the knowledge and skills necessary to apply the standards of care to their practices and healthcare settings for patients with NSCLC.